Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations.
While cyclosporine is recommended to be used only in conjunction with monitoring of its blood concentrations, the utility of these measurements in preventing treatment failure is not established. In a group of 52 patients trough levels and steady-state concentrations were monitored in serum and whole blood by specific (SP) and nonspecific (NS) assays (polyclonal radioimmunoassay, PR; fluorescence polarization immunoassay, FP; high-pressure liquid chromatography, HP). From as many as 10 determinations of trough level and steady state concentrations during the first 40 days after renal transplantation, the lowest measurement was selected. In the case of an acute rejection episode within that time period, only values until that event were considered. Trough level measurements in serum by PR/NS and by FP/NS and in whole blood by HP/SP were not significantly different between patients with and patients without rejection episodes. However, simultaneously measured steady-state values (serum/PR/NS and serum/FP/NS) were significantly lower in patients suffering from rejection (with rejection SS/serum/PR/NS mean = 127 ng/ml, SD = 41 ng/ml; without rejection mean = 163 ng/ml, SD = 60 ng/ml; P = 0.027, t test). This difference could not be demonstrated for steady state/whole blood/HP/SP measurements. A logistic regression analysis demonstrated that the probability of rejection can be decreased by up to 40% if steady state/serum/PR/NS or steady state/serum/FP/NS values never drop below 250 ng/ml early after renal transplantation.
Grevel
J
J
Department of Surgery, University of Texas Medical School, Houston 77030.
Napoli
K L
KL
Welsh
M S
MS
Atkinson
N E
NE
Kahan
B D
BD
D000293:Adolescent; D000328:Adult; D000368:Aged; D003524:Cyclosporins / Q000097:blood*; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D008875:Middle Aged; D012044:Regression Analysis
D003524:Cyclosporins